Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 256 results for "cipla"

Cipla Quarter 1 net profit down by 43.19 pct to Rs 365.24 crore
Financial Express

Cipla net dips 44%, CEO to step down

The article below represents a preview only and is not meant for reuse or republishing. New Delhi, Aug. 13 -- The country's fifthlargest drugmaker by sales, Cipla, on Friday reported a 44% decline in net profit to 365.2 crore during the April-June ... HT Syndication, 1 week ago
Cipla shares down 1.5% on disappointing Q1 earnings Business Standard, 1 week ago

226 images for cipla, 5 days ago
Financial Express, 5 days ago
Business Standard India, 5 days ago
Money Control, 5 days ago
Business Standard India, 1 week ago
Business Standard India, 1 week ago
Business Standard India, 1 week ago, 1 week ago
Financial Express, 8 hours ago
Financial Express, 14 hours ago

Cipla CEO heads for the exit as profits slump

Cipla's chief executive Subhanu Saxena is leaving the India-based generics maker at the end of this month amida shake-up in the company's operations. Saxena has been at the helm of Cipla since 2013, moving to the Indian drugmaker after a 14-year ...
 FiercePharma1 week ago Cipla rejigs top management, CEO Subhanu Saxena quits  Livemint.com1 week ago Top-level rejig at Cipla  Business Line1 week ago Cipla's global CEO resigns; elevates Samina Vasirelli as executive Vice chairman  Money Today1 week ago

Add Nifty positions above 8633; buy SBI, Cipla, Rajat Bose

According to Rajat Bose, Research Analyst at, one can sell Nifty if it were to stay below the 8665-mark with a stop loss above 8710; add more once the 8633-level gets taken out and bring down the stop loss to 8667, with next target at 8610 – ...
 Money Control2 days ago
India Infoline

Lupin named most reputed pharma brand in India

Lupin has been named as the most reputed pharmaceutical brand in India followed by Sun Pharma, Cipla and Dr.Reddys in that order in Indias Most Reputed Brands list. Among the global brands, GSK leads the way followed by Pfizer and Abbott. As many as 58 pharma ...
 The Hindu6 days ago Stocks to watch: Cipla, NHPC, NMDC, Jet, Allahabad, Infibeam  Moneycontrol.com1 week ago Top 24 stocks in focus today: Cipla, Aditya Birla Nuvo, SBI, Grasim  India Infoline1 week ago Results to watch out for! Sun Pharma,SBI, Cipla in focus  India Infoline1 week ago
Money Control

Cipla, Godrej recognised in Fortune 'Change the World' list

India's pharmaceutical giant Ciplaand consumer goods conglomerate Godrej have been recognised byFortune magazine in a list of global firms changing the worldfor the good and having a positive social impact through theiractivities.
 Money Control5 days ago Cipla, Godrej features in Fortune ‘Change the World’ list  Business Line5 days ago

Cipla, Godrej Consumer Products in 'Change the World' list

Two Indian companies -- Cipla and Godrej Consumer Products -- have been named in Fortune magazine's list of top 50 companies that are addressing global social problems as part of their core business strategy. The second annual 'Change the World' ...
 Business Standard6 days ago

Cipla to hold AGM

This page uses frames, but your browser doesn't
 Capital Market1 week ago Cipla announces change in Global CFO  Capital Market3 weeks ago

'Changes signal promoters' decision on succession plan'

Cipla, the country's fifth-largest drug company, witnessed more top-level changes on Friday. The Rs 13,000-crore company elevated its COO Umang Vohra as MD and global CEO and executive director Samina Vaziralli as executive vice-chairman. In an ...
 Times of India1 week ago Cipla slips as Supreme Court asks company to deposit Rs 175.07 crore for drug overcharging...  KJMC Group1 month ago CIPLA : slips as Supreme Court asks company to deposit Rs 175.07 crore for drug overcharging  4 Traders1 month ago
Business Standard India

India's Cipla Q1 profit lags estimates; names new CEO

MUMBAI, Aug 12 (Reuters) - Cipla Ltd, India's fifth-largest drugmaker by sales, reported a lower-than-expected quarterly profit as revenues in its home market were hit by government measures to cut drug prices. The company said it had appointed ...
 Sharenet1 week ago Cipla First Quarter Profit Lags Estimates; Names New CEO  Businessworld India1 week ago Cipla Q1 profit lags estimates; names new CEO  Reuters India1 week ago Indias Cipla Q1 profit lags estimates; names new CEO  Reuters UK1 week ago

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

GlobalData Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and ...
 MarketResearch.com2 weeks ago Cipla to hold board meeting  Business Standard2 weeks ago Cipla Ltd to announce Q1 results on August 12, 2016  Equity Bulls2 weeks ago Outcome of board meeting of Cipla  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less